Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥48.68
- Day Range
- ¥50.00–52.74
- 52-Week Range
- ¥35.79–52.74
- Bid/Ask
- ¥52.30 / ¥52.31
- Market Cap
- ¥333.62 Bil
- Volume/Avg
- 101.8 Mil / 29.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 58.46
- Price/Sales
- 13.05
- Dividend Yield (Trailing)
- 0.38%
- Dividend Yield (Forward)
- 0.38%
- Total Yield
- 0.38%
Company Profile
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 19,611
- Website
- http://www.hrs.com.cn
Comparables
Valuation
|
Metric
|
600276
|
600594
|
002793
|
|---|---|---|---|
Price/Earnings (Normalized) | 58.46 | — | — |
Price/Book Value | 7.83 | 1.11 | 2.12 |
Price/Sales | 13.05 | 1.20 | 2.09 |
Price/Cash Flow | 50.58 | 14.04 | — |
Price/Earnings
600276
600594
002793
Financial Strength
|
Metric
|
600276
|
600594
|
002793
|
|---|---|---|---|
Quick Ratio | 6.37 | 1.21 | 0.58 |
Current Ratio | 7.23 | 1.82 | 0.91 |
Interest Coverage | 953.21 | −3.36 | −8.58 |
Quick Ratio
600276
600594
002793
Profitability
|
Metric
|
600276
|
600594
|
002793
|
|---|---|---|---|
Return on Assets (Normalized) | 12.07% | −3.17% | −10.62% |
Return on Equity (Normalized) | 13.25% | −5.06% | −23.02% |
Return on Invested Capital (Normalized) | 11.64% | −3.17% | −11.96% |
Return on Assets
600276
600594
002793
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Qwhkkdxhfk | Sygs | $797.4 Bil | |||
| Johnson & Johnson
JNJ
| Kfgydmtz | Qggpp | $386.4 Bil | |||
| AbbVie Inc
ABBV
| Tdnhrwtl | Cfxq | $343.2 Bil | |||
| Merck & Co Inc
MRK
| Lycfcyh | Vzl | $278.2 Bil | |||
| AstraZeneca PLC ADR
AZN
| Dbrqbqvhm | Gjrfd | $246.0 Bil | |||
| Roche Holding AG ADR
RHHBY
| Npwgrzxl | Bxzx | $244.4 Bil | |||
| Novartis AG ADR
NVS
| Kwxppczf | Pdbcn | $232.2 Bil | |||
| Amgen Inc
AMGN
| Ymnjjgvf | Tgym | $171.8 Bil | |||
| Pfizer Inc
PFE
| Lbhdsrps | Dlll | $160.6 Bil | |||
| Sanofi SA ADR
SNY
| Zrsyhpf | Xylv | $138.8 Bil |
United States